Voyager Therapeutics, Inc.
VYGR
$3.17
-$0.26-7.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 236.02M | 266.68M | 345.36M | 371.02M | 399.57M |
| Total Receivables | 2.11M | 4.49M | 19.67M | 3.25M | 3.46M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.08M | 428.00K | 8.42M | 7.30M | 6.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 5.21M | -- | -- | -- |
| Total Current Assets | 245.21M | 276.81M | 373.44M | 381.57M | 409.14M |
|
|
|||||
| Total Current Assets | 245.21M | 276.81M | 373.44M | 381.57M | 409.14M |
| Net Property, Plant & Equipment | 46.06M | 47.66M | 49.72M | 51.78M | 56.59M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.87M | 2.87M | 2.87M | 2.87M | 2.89M |
| Total Assets | 353.24M | 393.05M | 426.04M | 436.23M | 469.59M |
|
|
|||||
| Total Accounts Payable | 2.63M | 4.00M | 3.16M | 2.61M | 7.58M |
| Total Accrued Expenses | 9.05M | 14.17M | 11.44M | 10.27M | 7.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.43M | 7.23M | 6.98M | 6.74M | 5.94M |
| Total Finance Division Other Current Liabilities | 21.10M | 24.39M | 22.63M | 20.52M | 51.44M |
| Total Other Current Liabilities | 21.10M | 24.39M | 22.63M | 20.52M | 51.44M |
| Total Current Liabilities | 40.21M | 49.79M | 44.21M | 40.13M | 72.55M |
|
|
|||||
| Total Current Liabilities | 40.21M | 49.79M | 44.21M | 40.13M | 72.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 34.57M | 36.50M | 38.37M | 40.21M | 42.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.76M | 7.00M | 13.15M | 20.47M | 14.16M |
| Total Liabilities | 80.54M | 93.29M | 95.73M | 100.81M | 128.71M |
|
|
|||||
| Common Stock & APIC | 630.11M | 626.35M | 622.04M | 618.59M | 613.90M |
| Retained Earnings | -357.21M | -326.18M | -291.70M | -282.65M | -272.51M |
| Treasury Stock & Other | -199.00K | -407.00K | -33.00K | -522.00K | -506.00K |
| Total Common Equity | 272.70M | 299.76M | 330.31M | 335.42M | 340.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 272.70M | 299.76M | 330.31M | 335.42M | 340.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 272.70M | 299.76M | 330.31M | 335.42M | 340.89M |
|
|
|||||